Hikari Power Ltd Makes New $5.62 Million Investment in Intuitive Surgical, Inc. $ISRG

Hikari Power Ltd acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 14,130 shares of the medical equipment provider’s stock, valued at approximately $5,619,000. Intuitive Surgical makes up about 0.7% of Hikari Power Ltd’s holdings, making the stock its 15th biggest position.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Brighton Jones LLC boosted its holdings in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares during the period. Sivia Capital Partners LLC increased its stake in Intuitive Surgical by 3.8% during the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after purchasing an additional 34 shares during the period. Schnieders Capital Management LLC. increased its stake in Intuitive Surgical by 38.0% during the second quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after purchasing an additional 268 shares during the period. Osterweis Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the second quarter worth about $200,000. Finally, Main Street Financial Solutions LLC lifted its position in shares of Intuitive Surgical by 92.4% during the second quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider’s stock worth $1,592,000 after purchasing an additional 1,407 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In related news, Director Gary S. Guthart sold 10,000 shares of the stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total value of $4,000,000.00. Following the transaction, the director owned 1,245,679 shares of the company’s stock, valued at $498,271,600. This represents a 0.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the sale, the executive vice president owned 5,320 shares in the company, valued at approximately $2,016,280. This represents a 6.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 17,088 shares of company stock valued at $6,941,913 in the last 90 days. Company insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several recent research reports. JPMorgan Chase & Co. lowered their price objective on shares of Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating for the company in a research note on Friday, July 17th. Sanford C. Bernstein reiterated an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday. HSBC cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target for the company. in a research report on Thursday, July 30th. BMO Capital Markets restated an “outperform” rating on shares of Intuitive Surgical in a research note on Monday, July 20th. Finally, Citigroup cut their price objective on Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. Twenty-two research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $508.68.

Intuitive Surgical Stock Performance

ISRG stock opened at $394.51 on Monday. The company’s 50 day moving average price is $391.45 and its 200 day moving average price is $440.66. The firm has a market capitalization of $139.37 billion, a price-to-earnings ratio of 45.19, a PEG ratio of 2.85 and a beta of 1.47. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same quarter in the previous year, the firm earned $1.81 earnings per share. The firm’s quarterly revenue was up 18.4% on a year-over-year basis. Equities analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.